PXMTF (PHAXIAM Therapeutics) Days Payable: 0.00 (As of Sep. 2023)

What is PHAXIAM Therapeutics Days Payable?

PHAXIAM Therapeutics PXMTF 38 Days Payable is 0.00 as of Sep. 2023. GuruFocus rates PXMTF with a GF Score™ of 38/100.

PHAXIAM Therapeutics's average Accounts Payable for the three months ended in Sep. 2023 was $4.70 Mil. PHAXIAM Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.00 Mil.

The historical rank and industry rank for PHAXIAM Therapeutics's Days Payable or its related term are showing as below:

PXMTF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.36
* Ranked among companies with meaningful Days Payable only.

PHAXIAM Therapeutics's Days Payable stayed the same from Jun. 2022 (0.00) to Sep. 2023 (0.00). stayed the same

PHAXIAM Therapeutics Days Payable Related Terms

PHAXIAM Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for PHAXIAM Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PHAXIAM Therapeutics Days Payable Chart

PHAXIAM Therapeutics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

0.00

PHAXIAM Therapeutics Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PXMTF vs VRTX, REGN, SGEN: Days Payable Comparison

For the Biotechnology subindustry, PHAXIAM Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PHAXIAM Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PHAXIAM Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where PHAXIAM Therapeutics's Days Payable falls into.

Save Embed

38GF Score

PHAXIAM Therapeutics SA PXMTF

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PHAXIAM Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

PHAXIAM Therapeutics's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (2.808	+	1.655)	/	2 )	/	0	*	365
=	2.2315					/	0	*	365
=	N/A

PHAXIAM Therapeutics's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (4.698	+	0)	/	1 )	/	0	*	365 / 4
=	4.698					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

PHAXIAM Therapeutics (PXMTF) has a Days Payable of 0.00 as of Sep. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PHAXIAM Therapeutics and its competitors.

Is PHAXIAM Therapeutics' Days Payable too high?

PHAXIAM Therapeutics' current Days Payable is 0.00. Overall, PHAXIAM Therapeutics has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.

How does PHAXIAM Therapeutics' Days Payable compare to VRTX and REGN?

PHAXIAM Therapeutics' Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.36, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PHAXIAM Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PHAXIAM Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PHAXIAM Therapeutics stock overvalued right now?

PHAXIAM Therapeutics (PXMTF) has a current Days Payable of 0.00. The current Days Payable is 0.00. PHAXIAM Therapeutics' overall GF Score™ is 38/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For PHAXIAM Therapeutics (PXMTF), the current Days Payable is 0.00 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PHAXIAM Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies XPAR:ALVIO XPAR:GNRO XPAR:ALGEN XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:ABNX XPAR:POXEL XPAR:FALG XPAR:ALHYG OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Address 60 Avenue Rockefeller, Lyon, FRA, 69008

Website https://www.phaxiam.com

PHAXIAM Therapeutics SA is a clinical-stage biopharmaceutical company developing therapies for severe forms of cancer and orphan diseases. Its platform uses a novel technology to encapsulate therapeutic drug substances inside erythrocytes, or red blood cells, or RBC. It is developing a pipeline of product candidates for patients with high unmet medical needs. Its product candidate eryaspase, also referred to as GRASPA, targets the metabolism of cancer cells by depriving the cells of asparagine, an amino acid necessary for their survival and critical in maintaining the cells' rapid growth rate. The company is developing for the treatment of severe tumors, including pancreatic cancer, acute lymphoblastic leukemia, or ALL, and triple-negative breast cancer, or TNBC.

38GF Score

Get the complete analysis for PXMTF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View PXMTF Analysis

See Days Payable data for all stocks →